Pages that link to "Q34493535"
Jump to navigation
Jump to search
The following pages link to Neuroprotective therapies for Alzheimer's disease (Q34493535):
Displaying 13 items.
- Mitochondria-Targeted Protective Compounds in Parkinson's and Alzheimer's Diseases (Q26859141) (← links)
- Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases (Q28388335) (← links)
- E2-25K/Hip-2 regulates caspase-12 in ER stress-mediated Abeta neurotoxicity (Q28508974) (← links)
- Advanced glycation endproducts as gerontotoxins and biomarkers for carbonyl-based degenerative processes in Alzheimer's disease. (Q37833105) (← links)
- Induced pluripotent stem cells as tools for disease modelling and drug discovery in Alzheimer's disease (Q38018504) (← links)
- Metabolic Biosynthesis of Potato (Solanum tuberosum l.) Antioxidants and Implications for Human Health. (Q38352743) (← links)
- Effects of long-term administration of a cocoa polyphenolic extract (Acticoa powder) on cognitive performances in aged rats (Q44734805) (← links)
- Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides (Q44901406) (← links)
- Inhibition of phosphodiesterase-4 reverses the cognitive dysfunction and oxidative stress induced by Aβ25-35 in rats (Q46589193) (← links)
- Formulation development and systematic optimization of solid lipid nanoparticles of quercetin for improved brain delivery (Q49058125) (← links)
- Methyl vinyl ketone induces apoptosis in murine GT1-7 hypothalamic neurons through glutathione depletion and the generation of reactive oxygen species. (Q52578664) (← links)
- A soluble amyloid fibril segment to study aggregate formation. (Q53382828) (← links)
- Therapeutic strategies for Alzheimer's disease (Q81527536) (← links)